1[1]Forns X, Gines A, Gines P, et al. Management of ascites and renal failure in cirrhosis. Semin Liver Dis, 1994,14:82-96.
2[2]Zervos EE, Rosemurgy AS. Management of medically refractory ascites. Am J Surg, 2001,181:256-264.
3[3]Gines P, Arroyo V, Rodes J. Pathophysiology, complications and treatment of ascites. Clin Liver Dis, 1997,1:129-155.
4[4]Somberg KA, Lake JR, Tomlanovich SJ, et al. Transjugular intrahepatic portosystemic shunts for refractory ascites: assessment of clinical and hormonal response and renal function. Hepatology, 1995,21:709-716.
5[5]Wong F, Sniderman K, Liu P, et al. The mechanism of the initial natriuresis after transjugular intrahepatic portosystemic shunt. Gastroenterology, 1997,112:899-907.
6[6]Arroyo V, Gines P, Gerbes A, et al. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. Hepatology, 1996,23:164-175.
7[7]Deschenes M, Dufresne MP, Bui B, et al. Predictors of clinical response to transjugular intrahepatic portosystemic shunts (TIPS) in cirrhotic patients with refractory ascites. Am J Gastroenterol, 1999,94:1361-1365.
8[8]Quiroga J, Sangro B, Nunez M, et al. Transjugular intrahepatic portal-systemic shunts in the treatment of refractory ascites: effect on clinical, renal, humoral, and hemodynamic parameters. Hepatology, 1995,21:986-994.
9[9]Ochs A, Rossle M, Haag K, et al. Transjugular intrahepatic portosystemic stent shunt procedure for refractory ascites. N Engl J Med, 1995,332:1192-1197.
10[10]Nazarian GK, Bjarnason H, Dietz CA, et al. Refractory ascites: midterm results of treatment with transjugular intrahepatic portosystemic shunt. Radiology, 1997,205:173-180.
